These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 1525350

  • 21. Detection of platelet-activating factor in exudates of rats with phorbol myristate acetate-induced pleurisy.
    Hayashi M, Kimura J, Yamaki K, Suwabe Y, Dozen M, Imai Y, Oh-ishi S.
    Thromb Res; 1987 Nov 01; 48(3):299-310. PubMed ID: 3433255
    [Abstract] [Full Text] [Related]

  • 22. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Effects on microvascular permeability, hypotension and nephrosis.
    Sakuma Y, Shirato M, Nagaoka J, Obaishi H, Tsunoda H, Katayama S, Ono H, Katayama K.
    Arzneimittelforschung; 1991 Dec 01; 41(12):1255-9. PubMed ID: 1815526
    [Abstract] [Full Text] [Related]

  • 23. Inhibition by WEB 2086, a PAG-acether antagonist of oedema and peritonitis induced by zymosan in rats.
    Damas J, Remacle-Volon G, Nguyen TP.
    Arch Int Pharmacodyn Ther; 1990 Dec 01; 306():161-9. PubMed ID: 2076045
    [Abstract] [Full Text] [Related]

  • 24. Platelet activating factor-induced microvascular permeability increases in the cat hindlimb.
    Lu Z, Wolf MB.
    Circ Shock; 1993 Sep 01; 41(1):8-18. PubMed ID: 8403248
    [Abstract] [Full Text] [Related]

  • 25. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J, Duval D, Prouteau M, Voltz C, Berry CN, Lloyd KG, Scatton B.
    Arzneimittelforschung; 1995 May 01; 45(5):559-68. PubMed ID: 7541995
    [Abstract] [Full Text] [Related]

  • 26. Interference of the PAF receptor antagonist, PCA 4248, with the rat pleurisy evoked by inflammatory mediators or allergen.
    Martins MA, Lima MC, Bozza PT, Faria Neto HC, Silva PM, Sunkel CE, Cordeiro RS.
    Eur J Pharmacol; 1993 Jun 11; 237(1):17-22. PubMed ID: 8395390
    [Abstract] [Full Text] [Related]

  • 27. Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig.
    Handley DA, Lee ML, Saunders RN.
    Thromb Haemost; 1985 Dec 17; 54(4):756-9. PubMed ID: 4089809
    [Abstract] [Full Text] [Related]

  • 28. Inhibitory effects of dexamethasone in endotoxic shock and its relation to PAF-acether synthesis in the gastrointestinal tract and lung.
    Ibbotson GC, Wallace JL.
    J Lipid Mediat; 1989 Dec 17; 1(5):273-82. PubMed ID: 2519897
    [Abstract] [Full Text] [Related]

  • 29. Mediators of inflammation and antagonism of experimental pleurisy in the rat by fenspiride.
    Lima MC, Hatmi M, Martins MA, Silva PM, Malanchère E, Cordeiro RN, Vargaftig BB.
    Rhinol Suppl; 1988 Dec 17; 4():85-92. PubMed ID: 2907679
    [No Abstract] [Full Text] [Related]

  • 30. Effect of azelastine on platelet-activating factor and antigen-induced pleurisy in rats.
    Lima MC, Martins MA, Perez SA, Silva PM, Cordeiro RS, Vargaftig BB.
    Eur J Pharmacol; 1991 May 17; 197(2-3):201-7. PubMed ID: 1680710
    [Abstract] [Full Text] [Related]

  • 31. Involvement of leukotrienes in allergic pleurisy in actively sensitized rats: inhibition by the lipoxygenase inhibitor T-0757 of the increase in vascular permeability and leukotriene E4 production.
    Kikuchi M, Tsuzurahara K, Suzuki T, Yato N, Naito K.
    Inflamm Res; 1996 Apr 17; 45(4):192-7. PubMed ID: 8741009
    [Abstract] [Full Text] [Related]

  • 32. Pharmacological modulation of PAF-acether-induced pleurisy in rats.
    Tarayre JP, Delhon A, Aliaga M, Bruniquel F, Barbara M, Puech L, Tisne-Versailles J, Couzinier JP.
    Pharmacol Res Commun; 1987 Dec 17; 19(12):859-76. PubMed ID: 3448610
    [Abstract] [Full Text] [Related]

  • 33. Enhanced exudation of fibrinogen into the perivascular space in acute inflammation triggered by neutrophil migration.
    Saito M, Shima C, Takagi M, Ogino M, Katori M, Majima M.
    Inflamm Res; 2002 Jul 17; 51(7):324-31. PubMed ID: 12146723
    [Abstract] [Full Text] [Related]

  • 34. [Analysis of chemical mediators involved in acute inflammatory reaction with the rat pleurisy model].
    Oh-ishi S.
    Nihon Yakurigaku Zasshi; 1997 Aug 17; 110(2):59-68. PubMed ID: 9306414
    [Abstract] [Full Text] [Related]

  • 35. Effect of endotoxin and platelet-activating factor on rat vascular permeability: role of vasoactive mediators.
    Balsa D, Merlos M, Giral M, Ferrando R, Garcia-Rafanell J, Forn J.
    J Lipid Mediat Cell Signal; 1997 Sep 17; 17(1):31-45. PubMed ID: 9302653
    [Abstract] [Full Text] [Related]

  • 36. Pharmacological demonstration of inflammatory mediators using experimental inflammatory models: rat pleurisy induced by carrageenin and phorbol myristate acetate.
    Oh-ishi S, Hayashi I, Hayashi M, Yamaki K, Utsunomiya I.
    Dermatologica; 1989 Sep 17; 179 Suppl 1():68-71. PubMed ID: 2673856
    [Abstract] [Full Text] [Related]

  • 37. Increase in vascular permeability produced in rat airways by PAF: potentiation by adrenalectomy.
    Boschetto P, Musajo FG, Tognetto L, Boscaro M, Mapp CE, Barnes PJ, Fabbri LM.
    Br J Pharmacol; 1992 Feb 17; 105(2):388-92. PubMed ID: 1559129
    [Abstract] [Full Text] [Related]

  • 38. Suppression of the Arthus reaction by Y-24180, a potent and specific antagonist of platelet-activating factor.
    Okamoto H, Iwahisa Y, Terasawa M.
    Agents Actions; 1992 Mar 17; 35(3-4):149-58. PubMed ID: 1388318
    [Abstract] [Full Text] [Related]

  • 39. Permeability-increasing ability of PAF-acether in rat skin.
    Gerdin B, Lundberg C, Smedegøard G.
    Inflammation; 1985 Mar 17; 9(1):107-12. PubMed ID: 3980073
    [Abstract] [Full Text] [Related]

  • 40. Platelet-activating factor and the vascular effects of zymosan in rats.
    Damas J, Remacle-Volon G, Bourdon V.
    Eur J Pharmacol; 1993 Feb 09; 231(2):231-6. PubMed ID: 8453979
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.